This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignee: The University of Mississippi. Active years: 2010-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2019
Title: The Innovative Contributions of Mahmoud Elsohly in Antidermatitis Solutions
Introduction: Mahmoud Elsohly is a distinguished inventor based in Oxford, MS. His significant contributions to the field of dermatological innovations are evidenced by his two patents, which focus on treatments for skin conditions resulting from environmental allergens.
Latest Patents: Elsohly's latest patent, titled "Compositions for Prevention/Prophylactic Treatment of Poison Ivy Dermatitis," introduces groundbreaking compositions that utilize derivatives of 3-n-pentadecylcatechol and 3-n-heptadecyl catechol. These compounds aim to prevent and treat contact dermatitis caused by exposure to poison ivy and poison oak. The inventive process not only outlines the formulation of these derivatives but also includes methods for their synthesis. Alongside this, he has developed an innovative water-soluble polysaccharide fraction known for its potent immunostimulatory activity. This fraction, exhibiting a high molecular weight, is constituted mainly of glucose, galactose, mannose, and arabinose. These compositions are designed for use in pharmaceutical treatments and dietary supplements, showcasing their versatility in immunotherapy.
Career Highlights: Mahmoud Elsohly works at the University of Mississippi, where he has engaged in research that bridges the gap between science and practical health solutions. His dedication to finding advancements in therapeutic options for allergic reactions has positioned him as a key figure in his field.
Collaborations: Elsohly has collaborated with notable colleagues such as David Stanley Pasco and Nirmal Pugh. These partnerships have likely enriched his research and contributed to the successful development of his patented inventions.
Conclusion: Mahmoud Elsohly exemplifies the innovative spirit in the realm of dermatological research. His patents not only aim to alleviate symptoms of poison ivy dermatitis but also explore broader applications in immunostimulation. As he continues to push the boundaries of traditional treatment methods, Elsohly remains a significant contributor to advancements in public health through his work at the University of Mississippi.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile